Friday, April 26, 2024 4/26/2024

A multiplexed micro scale assay for real time analysis of pediatric immune cell function

Award Number: U24AI152177
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Abstract Restricted amounts of biological samples that can be collected from pediatric patients for the study of immune function are often insuf¿cient for conventional assays. Development of novel, multi-parameter sample sparing assays is necessary for advancing the fundamental understanding of the immune system. In this proposal, we outline three aims which detail the addition and integration of new biological readouts to an existing micro¿uidic technology and the use of this expanded platform to investigate the mechanisms for how allergies and asthma develop in children. The kit-on-a-lid- assay (KOALA) is an easy to use self-contained micro¿uidic platform which is capable of isolating neutrophils from whole blood, and assessing their chemotactic abilities. In Aim 1 we propose to adapt and validate assays for measuring neutrophil ROS production, NETosis, phagocytosis, cytokine production, and gene expression (RT- qPCR) into KOALA. We also plan to modify the cell capture speci¿city of KOALA to allow us to isolate T cells from whole blood and assess their cytokine production and gene expression (RT-qPCR). The last component of Aim 1 is to test and compare a new, less invasive blood draw method called Hemolink™ against traditional blood draw methods in terms of immune cell phenotype. In Aim 2 we propose to use a single-cell real-time non-invasive label-free microscopy method called optical metabolic imaging (OMI) to identify single-cell heterogeneity in activation within T cell and neutrophil populations. OMI is compatible with the other endpoints and can be run simultaneously. In Aim 3 will apply our multiplexed KOALA assays to blood samples from a cohort of children with allergic disease and matched healthy controls from the WISC cohort (an ongoing study at UW that includes farm and non-farm children). We will compare our neutrophil and T cell function and phenotype results from these children with the extensive measurements being done as part of the WISC cohort study. In Aim 3 we will also extend these analyses to a group of infants from the CREW study (a new study at UW that aims to identify early life genetic and environmental risk factors for allergic diseases and asthma) using the HemoLink™ device to draw blood with minimal discomfort and pro¿le type 2 T cell function (T cells differentiated to secrete IL-4, IL-5, IL-13 and other type 2 cytokines) using KOALA. If successful in our aims, we will have created a miniaturized, highly multiplexed, self-contained micro¿uidic platform that is capable of measuring biological markers related to immune status and function. This system will have then been validated in pediatric subjects and ready for transition into clinical research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $354,245 )
2024	2024	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	000	5	4/3/2024	NON-COMPETING CONTINUATION	$354,245
														Subtotal = $354,245

Issue Date FY: 2023 ( Subtotal = $357,370 )
2023	2023	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	001	4	3/28/2023	NON-COMPETING CONTINUATION	$357,370
2023	2021	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	000	2	2/8/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $357,370

Issue Date FY: 2022 ( Subtotal = $360,396 )
2022	2022	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	000	3	3/31/2022	NON-COMPETING CONTINUATION	$360,396
2022	2022	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	001	3	9/14/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $360,396

Issue Date FY: 2021 ( Subtotal = $363,102 )
2021	2021	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	001	2	8/12/2021	NON-COMPETING CONTINUATION	$0
2021	2021	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	000	2	3/31/2021	NON-COMPETING CONTINUATION	$363,102
														Subtotal = $363,102

Issue Date FY: 2020 ( Subtotal = $379,007 )
2020	2020	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6401	MADISON	WI	53715	DANE	USA	Allergy and Infectious Diseases Research	000	1	3/25/2020	NEW	$379,007
														Subtotal = $379,007

Grand Total All Awards = $1,814,120

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A multiplexed micro scale assay for real time analysis of pediatric immune cell function

Award Number: U24AI152177

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer